Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation

By Wang J.   Zganiacz A.   Xing Z.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2887-2898

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

By Thoelen S.   Van Damme P.   Mathei C.   Leroux-Roels G.   Desombere I.   Safary A.   Vandepapeliere P.   Slaoui M.   Meheus A.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 708-714

Elsevier

Access to resources Recommend Favorite

Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine

By Yung C.Y.   Yoshimatsu K.   Koike Y.   Hatsuse R.   Yamanishi K.   Tanishita O.   Arikawa J.   Azuma I.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 216-224

Elsevier

Access to resources Recommend Favorite

Erratum to ''Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide'' [Vaccine 19 (2001) 1068-1081]

By Frangione-Beebe M.   Albrecht B.   Dakappagari N.   Travis Rose R.   Brooks C.L.   Schwendeman S.P.   Lairmore M.D.   Kaumaya P.T.P.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4087-4087

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

By Gilbert S.C.   Schneider J.   Hannan C.M.   Hu J.T.   Plebanski M.   Sinden R.   Hill A.V.S.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1039-1045

Elsevier

Access to resources Recommend Favorite